Differential response of premalignant epithelial cell classes to phorbol ester tumor promoters and to deoxycholic acid.
The effects of two agents, 12-O-tetradecanoylphorbol-13-acetate (TPA) and deoxycholic acid (DOC), which act as tumor promoters in the gastrointestinal epithelium of experimental animals, were compared using primary cultures of human premalignant colonic epithelial cells at different stages in tumor progression. Both DOC and TPA enhanced the size of the proliferative fraction in colonies of early-stage premalignant cells, with DOC providing more stimulation. TPA-treated intermediate- and late-stage premalignant cells elongated and then disrupted the monolayer by forming rills several cells in thickness and then multicellular clusters. This multilayering was reminiscent of the areas of carcinoma found within adenomas. DOC had no such effects on morphology. Cell clustering was concomitant with secretion of a protease with characteristics of a plasminogen activator. Premalignant cells secreted severalfold higher levels of protease in response to TPA than did either TPA-treated primary cultures of colonic adenocarcinomas or established colon carcinoma cell lines. These results suggest that (a) DOC and TPA act sequentially during tumor promotion and (b) cell clustering and protease release may be associated with the transition of premalignant epithelial cells to colonic carcinoma.
D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced; D002478:Cells, Cultured; D003110:Colonic Neoplasms / Q000378:metabolism / Q000473:pathology*; D004261:DNA Replication / Q000187:drug effects; D003840:Deoxycholic Acid / Q000494:pharmacology*; D004848:Epithelium / Q000187:drug effects / Q000473:pathology; D006801:Humans; D010447:Peptide Hydrolases / Q000032:analysis / Q000378:metabolism; D010704:Phorbols / Q000494:pharmacology*; D010960:Plasminogen Activators / Q000378:metabolism; D011230:Precancerous Conditions / Q000378:metabolism / Q000473:pathology*; D011480:Protease Inhibitors; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D010704:Phorbols; D011480:Protease Inhibitors; D003840:Deoxycholic Acid; D010447:Peptide Hydrolases; D010960:Plasminogen Activators; D013755:Tetradecanoylphorbol Acetate